CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid‑In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		119,426,064
Beginning balance at Dec. 31, 2021	$ 738,426	$ 119	$ 0	$ 913,581	$ (7,866)	$ (167,408)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		842,188
Exercise of stock options	5,203	$ 1		5,202
Vesting of restricted stock units (in shares)		1,895,620
Vesting of restricted stock units	2	$ 2
Issuance of common stock under the employee stock purchase plan (in shares)		295,189
Issuance of common stock under the employee stock purchase plan	6,840			6,840
Issuance of common stock in connection with business combination (in shares)		711,111
Issuance of common stock in connection with business combination	15,083	$ 1		15,082
Stock-based compensation	109,170			109,170
Foreign currency translation adjustment	(32,085)				(32,085)
Net loss	(141,301)					(141,301)
Ending balance (in shares) at Dec. 31, 2022		123,170,172
Ending balance at Dec. 31, 2022	701,338	$ 123	0	1,049,875	(39,951)	(308,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		845,235
Exercise of stock options	6,042	$ 1		6,041
Vesting of restricted stock units (in shares)		2,489,574
Vesting of restricted stock units	2	$ 2
Issuance of common stock under the employee stock purchase plan (in shares)		433,121
Issuance of common stock under the employee stock purchase plan	6,077			6,077
Stock-based compensation	101,000			101,000
Foreign currency translation adjustment	13,174				13,174
Net loss	(110,086)					(110,086)
Ending balance (in shares) at Dec. 31, 2023		126,938,102
Ending balance at Dec. 31, 2023	717,547	$ 126	0	1,162,993	(26,777)	(418,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase and retirement of common stock (in shares)		(2,000,000)
Repurchase and retirement of common stock	(35,357)	$ (2)				(35,355)
Exercise of stock options (in shares)		620,889
Exercise of stock options	3,726	$ 1		3,725
Vesting of restricted stock units (in shares)		3,438,266
Shares repurchased for tax withholdings on vesting of restricted stock (in shares)		(44,215)
Shares repurchased for tax withholdings on vesting of restricted stock	(741)		(741)
Issuance of common stock under the employee stock purchase plan (in shares)		378,988
Issuance of common stock under the employee stock purchase plan	5,156			5,156
Stock-based compensation	97,390			97,390
Foreign currency translation adjustment	(3,283)				(3,283)
Net loss	(68,455)					(68,455)
Ending balance (in shares) at Dec. 31, 2024		129,332,030
Ending balance at Dec. 31, 2024	$ 715,983	$ 125	$ (741)	$ 1,269,264	$ (30,060)	$ (522,605)